Medibank — Power Map

Medibank Opal 2026 Stage: Proof-of-Value Value: $53K (AUD ~100K pilot) Close: 2026-03-27 Updated: 2026-03-11
Champion
Economic Buyer
Technical
Blocker / Process
Unknown / External
Optimizely
Tier 1 — Executive
Economic Buyer
Geoff Ikin
CMO
Economic Buyer. April SVA presentation target. Jon Goh reports to him. Sign-off required for larger investment for new financial year.
Tier 2 — Champions
Champion
Jon Goh
Head of Marketing Technology
Elevated to champion 3/3. Wants Optimizely “front and center of this reshaping of marketing.” Hub-and-spoke org model with ~48 squads. ~$2M discretionary agency spend to reclaim. Interested in US visit and Salesforce customer references. Covers all 3 BUs. Adoption is his #3 risk (after funding and capability) — cited past failures with workflow tool adoption (per 3/3 follow-up). FY27 funding from Geoff Ikin required for enterprise-wide deployment. Confirmed Medibank on Microsoft Teams; Teams agent activation in scope. Expressed interest in collaborating on Optimizely roadmap (directed to Shaf).
Champion
Simon Tsang
Content & SEO Squad Lead
Primary champion driving evaluation. Reports to Jon Goh.
Champion
Sophie Jackson
Content and Publications Editor
Operational champion. Owns day-to-day pain. Called agent demo “super great” and “super exciting.” Had pre-built clinical agent brief. Primary pilot user.
Champion
Jono Santamaria
 
Emerging champion. Actively shaping pilot requirements, pushing for structured feedback. Offering to support procurement conversations.
Tier 3 — Evaluators
Evaluator
Jamie Crighton
Marketing Automation Manager
Evaluator.
Evaluator
Josh Pike
MarTech Platforms Lead
Evaluator. On parental leave until May — deeper architecture and integration work deferred until return. (per 3/3 follow-up)
Tier 4 — Blockers / Process
Blocker — Process
AI Governance Committee
 
Hard gate for approval. CIRA form pending completion. Approval required before procurement can proceed.
Blocker — Process
Procurement
 
Not yet engaged. Even POC terms need procurement involvement. Flagged as urgent by Jono (2/24).
External Influencers
External Advisory
McKinsey
 
Advisory role on AI transformation. Not a product competitor but shaping requirements. “Briefs don’t exist” vision. Influential voice.
Optimizely — To Loop In
Kevin Lee
SVP Product Strategy
Surfaced 3/3: Jon Goh wants cross-channel media optimization integration — creative variant testing across Google Display, Instagram, EDM. Needs technical conversation with Kevin Lee. Some API/GA4 capability exists today; walled-garden platforms remain a constraint.

Signature Path

1
Champion Validation
Jon Goh
Done — elevated to champion 3/3.
2
Custom Demo
Target week of March 10
Pending. Erik fine-tuning. Audience may widen to AHM/Ampler Health.
3
Commercials Walkthrough
Within 1–2 days of 3/3
Pending. Sophie, Simon Tsang, Jon Goh.
4
AI Governance
CIRA Form
Gap — pending. Hard gate. No visibility into timeline.
5
Procurement
Not yet engaged
Gap. Even POC needs procurement. Change order, not new agreement.
6
Pilot Sign-off
Jon Goh / Simon Tsang
Pending. 100K AUD pilot order.
7
CMO Approval
Geoff Ikin
Pending. April SVA presentation for larger investment.

Informal Influence Network

Jon Goh → reports to → Geoff Ikin (CMO). Drives centralized marketing technology across all 3 BUs. “Mold our operations around this Optimizely brain.”
Simon Tsang → reports to → Jon Goh. Primary evaluation driver. Content & SEO squad lead.
Sophie Jackson is the strongest operational advocate. Day-to-day user who owns the clinical content pain. “Super exciting” reaction to agents.
McKinsey → shaping → AI transformation requirements for Medibank. Target state: “briefs don’t exist.” Influential voice with leadership.
Jono Santamaria — pushing for structured process and procurement engagement. Offering to bridge operational requirements to procurement conversations.

Map Gaps

Who drives AI Governance Committee approval?
CIRA form status unknown. Committee approval is a hard gate before procurement can proceed.
Jono completing CIRA form. Need visibility into committee timeline and decision-maker.
Procurement contact?
Not yet engaged even for POC terms. Flagged as urgent 2/24.
Simon to talk to Jon Goh about who to engage. Existing contract (change order) simplifies but doesn’t eliminate.
Demo audience scope?
May widen to include AHM/Ampler Health for internal buy-in. Adds complexity to demo preparation. 3/3 note confirms audience: Sophie, Julia, Simon Tsang, Jon Goh + core team.
Mark confirming with Simon Tsang. Who is “Julia” — unidentified attendee listed in 3/3 scheduling. Audience expansion could strengthen multi-BU business case.
Intelligence Bank DAM replacement?
NOT decided (contrary to handover intel). Asset migration 6–8 weeks, excluded from pilot.
Do not position DAM replacement in pilot scope. Separate conversation for full-scale deal.
Geoff Ikin’s priorities and objections?
No direct Optimizely-to-Geoff relationship. April SVA presentation is the target but no pre-engagement.
Build SVA model with Medibank data. Jon Goh is the path to Geoff.
VIN products team readiness?
Pet, travel, life added to pilot scope but readiness unknown. Additional agent build within existing 40-hour SOW.
Confirm VIN team availability and content requirements during demo planning.
Josh Pike gap during parental leave?
Josh Pike (MarTech Platforms Lead) is on parental leave until May. He is the primary technical evaluator for platform and integration architecture. (per 3/3 follow-up)
Deeper architecture and integration discussions deferred until May. Identify interim technical contact or proceed without MarTech lead input for pilot phase.
FY27 funding secured for full deployment?
Jon Goh confirmed pilot funding in place, but enterprise-wide deployment requires FY27 budget approval from Geoff Ikin (CMO). April SVA is the gate. (per 3/3 follow-up)
Pilot must generate clear proof points to support Geoff Ikin’s April SVA sign-off. Build SVA model with Medibank data before that meeting.